Arthritis, Musculoskeletal and Skin Diseases Research in Massachusetts
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $310 million to recipients in Massachusetts in 311 grants from fiscal 2021 to 2025, 12% of the program's national total. Brigham & Womens Hospital Inc received the most, $95.7 million.
- Awarded in Massachusetts$310 million
- Awards311
- Share of the program12%
- Rank among states3rd of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 154 | $55.3 million |
| FY 2022 | 159 | $63.8 million |
| FY 2023 | 153 | $62.8 million |
| FY 2024 | 147 | $63.6 million |
| FY 2025 | 149 | $64.5 million |
Recipients in Massachusetts
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Brigham & Womens Hospital Inc | Nonprofits | 89 | $95.7 million |
| The General Hospital Corporation | Nonprofits | 59 | $63.5 million |
| The Children's Hospital Corporation | Nonprofits | 32 | $30.0 million |
| University of Massachusetts Medical School | Colleges and universities | 21 | $25.4 million |
| President and Fellows of Harvard College | Colleges and universities | 18 | $17.5 million |
| Trustees of Boston University | Colleges and universities | 17 | $16.6 million |
| Trustees of Boston University | Colleges and universities | 11 | $13.1 million |
| President and Fellows of Harvard College | Colleges and universities | 14 | $10.6 million |
| Beth Israel Deaconess Medical Center, Inc. | Nonprofits | 4 | $6.5 million |
| Hebrew Rehabilitation Center | Nonprofits | 5 | $6.0 million |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to Massachusetts?
$310 million from fiscal 2021 to 2025, across 311 awards. Massachusetts ranks 3rd of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in Massachusetts?
The largest recipient is Brigham & Womens Hospital Inc, with $95.7 million in 89 awards. Next are The General Hospital Corporation and The Children's Hospital Corporation.
Can organizations in Massachusetts apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in Massachusetts
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- National School Lunch Program
- Allergy and Infectious Diseases Research
- Aging Research